These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8271900)

  • 1. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI.
    Canet E; Revel D; Forrat R; Baldy-Porcher C; de Lorgeril M; Sebbag L; Vallee JP; Didier D; Amiel M
    Magn Reson Imaging; 1993; 11(8):1139-45. PubMed ID: 8271900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
    Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional magnetic resonance imaging (MRI) of hepatic ischemia in the rabbit. Contribution of a particulated contrast agent (AMI-25)].
    Canet E; Roger T; Chambon C; Delabre C; Baldy C; Revel D
    Anat Histol Embryol; 1996 Mar; 25(1):23-9. PubMed ID: 8644929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging with superparamagnetic iron oxide particles for the detection of myocardial reperfusion.
    Rozenman Y; Zou XM; Kantor HL
    Magn Reson Imaging; 1991; 9(6):933-9. PubMed ID: 1766318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients.
    Nighoghossian N; Wiart M; Cakmak S; Berthezène Y; Derex L; Cho TH; Nemoz C; Chapuis F; Tisserand GL; Pialat JB; Trouillas P; Froment JC; Hermier M
    Stroke; 2007 Feb; 38(2):303-7. PubMed ID: 17170357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation.
    Küstermann E; Roell W; Breitbach M; Wecker S; Wiedermann D; Buehrle C; Welz A; Hescheler J; Fleischmann BK; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):362-70. PubMed ID: 15948224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients].
    Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny EJ; Shamsi K; Balzer T; Peters PE
    Rofo; 1998 Mar; 168(3):228-36. PubMed ID: 9551108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
    Chambon C; Clement O; Le Blanche A; Schouman-Claeys E; Frija G
    Magn Reson Imaging; 1993; 11(4):509-19. PubMed ID: 8316064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.
    Reimer P; Müller M; Marx C; Wiedermann D; Muller R; Rummeny EJ; Ebert W; Shamsi K; Peters PE
    Radiology; 1998 Dec; 209(3):831-6. PubMed ID: 9844683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bolus volume and dose of gadolinium chelate for first-pass myocardial perfusion MR imaging studies.
    Canet E; Douek P; Janier M; Bendid K; Amaya J; Millet P; Revel D
    J Magn Reson Imaging; 1995; 5(4):411-5. PubMed ID: 7549202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
    Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
    J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-pass evaluation of renal perfusion with TurboFLASH MR imaging and superparamagnetic iron oxide particles.
    Trillaud H; Grenier N; Degreze P; Louail C; Chambon C; Franconi JM
    J Magn Reson Imaging; 1993; 3(1):83-91. PubMed ID: 8428106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study.
    Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Tombach B
    Radiology; 2004 May; 231(2):474-81. PubMed ID: 15044749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
    Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
    AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model.
    Bjerner T; Ericsson A; Wikström G; Johansson L; Nilsson S; Ahlström H; Hemmingsson A
    J Magn Reson Imaging; 2000 Dec; 12(6):866-72. PubMed ID: 11105024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.